Equities

Cross Country Healthcare Inc

Cross Country Healthcare Inc

Actions
IndustrialsIndustrial Support Services
  • Price (USD)14.96
  • Today's Change0.150 / 1.01%
  • Shares traded507.36k
  • 1 Year change-37.69%
  • Beta0.6387
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy2
Outperform1
Hold5
Sell0
Strong Sell0

Share price forecast in USD

The 5 analysts offering 12 month price targets for Cross Country Healthcare, Inc. have a median target of 19.00, with a high estimate of 19.00 and a low estimate of 17.00. The median estimate represents a 27.01% increase from the last price of 14.96.
High27.0%19.00
Med27.0%19.00
Low13.6%17.00

Earnings history & estimates in USD

On Jul 31, 2024, Cross Country Healthcare, Inc. reported 2nd quarter 2024 earnings of 0.10 per share.
The next earnings announcement is expected on Oct 30, 2024.
Average growth rate-37.74%
Cross Country Healthcare, Inc. reported annual 2023 earnings of 2.33 per share on Feb 21, 2024.
Average growth rate+197.08%
More ▼

Revenue history & estimates in USD

Cross Country Healthcare, Inc. had 2nd quarter 2024 revenues of 339.77m. This bettered the 334.76m consensus of the 9 analysts covering the company. This was 45.44% below the prior year's 2nd quarter results.
Average growth rate-10.85%
Cross Country Healthcare, Inc. had revenues for the full year 2023 of 2.02bn. This was 28.04% below the prior year's results.
Average growth rate+35.38%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.